胸腺鳞状细胞癌-相关VIP免费

全部翻完ThymicSquamousCellCarcinomas作为关键词的19页结果。差不多是case居多，还有症状，自己看看吧，应该已包含全部有该完整关键词的文章！可能有漏，觉得不够你也可以自己翻。不过建议不要浪费时间再翻，可以搜其他关键词。祝你研究顺利AllesGute.看到我眼睛痛！！！！p.s每篇上面的是链接，不过我都是全部复制过来，建议如果你觉得这个作者说的有道理可以点开查看相关介绍的链接。如果觉得差不多就不用每个点开了。希望能帮到你！加油！！晚期的多峰性治疗胸腺癌link:http://www.ncbi.nlm.nih.gov/pubmed/25311849GenThoracCardiovascSurg.2015Mar;63(3):159-63.doi:10.1007/s11748-014-0486-7.Epub2014Oct14.Multimodalitytreatmentforadvancedthymiccarcinoma:outcomesofinductiontherapyfollowedbysurgicalresectionin16casesatasingleinstitution.ShintaniY1,InoueM,KawamuraT,FunakiS,MinamiM,OkumuraM.Authorinformation1DepartmentofGeneralThoracicSurgery,OsakaUniversityGraduateSchoolofMedicine,2-2-L5Yamadaoka,Suita,Osaka,565-0871,Japan,yshintani@thoracic.med.osaka-u.ac.jp.AbstractOBJECTIVE:Wereviewedourinstitutionalexperiencewithcasesofmultimodalitytreatmentforadvancedthymiccarcinomatodeterminepatientoutcomesandprognosticindicators.METHODS:Between1998and2014,16patientswithaMasaokastageIIIorIVthymiccarcinomaunderwentsurgicalresectionafterinductiontherapyatOsakaUniversityHospital.Thesewereconsideredtohavegreatvesselinvasionormetastasistothemediastinalorintrathoraciclymphnodesbasedonthepreoperativeworkupfindings,andreceivedinductiontherapy.RESULTS:Completetumorresectionwasachievedin11(69%)aftertheinductiontherapy.Pathologicalfindingsrevealedthat10patientshadMasaokastageIIIdisease,1hadIVa,and5hadIVb.Thehistologicaldiagnosiswassquamouscellcarcinomain13,neuroendocrinecarcinomain2,andundifferentiatedcarcinomain1.The5-yearsurvivalrateforallpatientswas71%.Survivalwassignificantlybetterinpatientswhounderwentacompleteresection(R0disease)ascomparedtothosewithincompletelyresectedtumors(R1orR2disease).CONCLUSIONS:Multimodalitytreatmentoffersencouragingresultsandcompleteresectionprovideshighsurvivalrateforpatientswithadvancedthymiccarcinoma.link:http://www.ncbi.nlm.nih.gov/pubmed/25629460Long-TermOutcomesofSurgeryforThymicCarcinoma:Experienceof25CasesataSingleInstitution.TagawaT1,SuzukiH1,NakajimaT1,IwataT1,MizobuchiT1,YoshidaS1,YoshinoI1.AuthorinformationAbstractBackgroundThymiccarcinoma,arelativelyrareentity,oftenpresentsaslocallyadvanceddisease,andsometimesasdistantmetastaticdisease.Thetreatmentstrategy,long-termsurgicaloutcomesandclinicalprognosticfactorshaveyettobefullyelucidated.MethodsClinicalchartsof25patientswhounderwentsurgeryforthymiccarcinomaatourinstitutionfrom1991to2014wereretrospectivelyreviewed.ResultsTheMasaokastagewasstageIinthreepatients(12%),IIineight(32%),IIIinfour(16%),IVainfour(16%),andIVbinsix(24%).Histologicsubtypesweresquamouscellcarcinomain12patients,well-differentiatedneuroendocrinecarcinomain5,undifferentiatedcarcinomain3,adenocarcinomain1,andothersin4.Threepatientshadparaneoplasticsyndromeincludingmyastheniagravis,multipleendocrineneoplasiatype1(MEN1),andCushingsyndrome.Neoadjuvantchemotherapywasadministeredtofivepatients(20%).Completeresectionwasachievedin17patients(68%).Therewerenoperioperativedeaths.Twelvepatientsreceivedpostoperativetherapy.The5-and10-yearoverallsurvivalrateswere76.2and63.5%,respectively.The5-and10-yearsurvivalratesofpatientswithMasaokastageI-IIIwere88.9and74.1%,respectively,whereasthe5-y...